Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease

Neurobiology of Aging

Volumn 33, Issue 9, 2012, Pages 1995-2005

  Poisnel, Géraldine ^a,b,c,d   Hérard, Anne Sophie ^b,c   El Tannir El Tayara, Nadine ^e,f   Bourrin, Emmanuel ^b,c,d   Volk, Andreas ^e,f   Kober, Frank ^g   Delatour, Benoit ^h,i,j   Delzescaux, Thierry ^b,c   Debeir, Thomas ^a   Rooney, Thomas ^a   Benavides, Jésus ^a   Hantraye, Philippe ^b,c   Dhenain, Marc ^b,c  

^a Therapeutic Strategic Unit Aging Alzheimer/Parkinson/Stroke   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^c SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^d INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^e Centre Universitaire   (France)

^f INSTITUT CURIE   (France)

^g University of Aix Marseille   (France)

^h CNRS   (France)

ⁱ INSERM   (France)

^j SORBONNE UNIVERSITÉ   (France)

more..

Author keywords

14C 2 deoxyglucose; 18F FDG PET; Alzheimer; Amyloid; APP PS1 transgenic mice; Biomarker; Cerebral glucose uptake

Indexed keywords

AMYLOID PRECURSOR PROTEIN; FLUORODEOXYGLUCOSE F 18; GLUCOSE; PRESENILIN 1;

ALZHEIMER DISEASE; AMYLOID PLAQUE; AMYLOIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUTORADIOGRAPHY; BIOMICROSCOPY; BRAIN CORTEX; BRAIN PERFUSION; BRAIN RADIOGRAPHY; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GLUCOSE BRAIN LEVEL; GLUCOSE TRANSPORT; HIPPOCAMPUS; MICROGLIA; MOLECULAR PATHOLOGY; MOUSE; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THREE DIMENSIONAL IMAGING;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; CALCIUM-BINDING PROTEINS; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; FLUORODEOXYGLUCOSE F18; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROFILAMENT PROTEINS; POSITRON-EMISSION TOMOGRAPHY; PRESENILIN-1;

EID: 84863433664     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.09.026     Document Type: Article

References (53)

1. Barrio J.R., Kepe V., Satyamurthy N., Huang S.C., Small G. Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment. J. Nutr. Health Aging 2008, 12:61S-65S.
2. Bell R.D., Zlokovic B.V. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 2009, 118:103-113.
3. Blanchard V., Moussaoui S., Czech C., Touchet N., Bonici B., Planche M., Canton T., Jedidi I., Gohin M., Wirths O., Bayer T.A., Langui D., Duyckaerts C., Tremp G., Pradier L. Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice. Exp. Neurol 2003, 184:247-263.
4. Bolmont T., Haiss F., Eicke D., Radde R., Mathis C.A., Klunk W.E., Kohsaka S., Jucker M., Calhoun M.E. Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance. J. Neurosci 2008, 28:4283-4292.
5. Bourasset F., Mélissa O., Tremblay C., Julien C., Do T.M., Oddo S., Laferla F., Calon F. Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease. Neuropharmacology 2009, 56:808-813.
6. Busche M.A., Eichhoff G., Adelsberger H., Abramowski D., Wiederhold K.H., Haass C., Staufenbiel M., Konnerth A., Garaschuk O. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 2008, 321:1686-1689.
7. Choo I.H., Lee D.Y., Youn J.C., Jhoo J.H., Kim K.W., Lee D.S., Lee J.S., Woo J.I. Topographic patterns of brain functional impairment progression according to clinical severity staging in 116 Alzheimer disease patients: FDG-PET study. Alzheimer Dis. Assoc. Disord 2007, 21:77-84.
8. Cohen A.D., Price J.C., Weissfeld L.A., James J., Rosario B.L., Bi W., Nebes R.D., Saxton J.A., Snitz B.E., Aizenstein H.A., Wolk D.A., Dekosky S.T., Mathis C.A., Klunk W.E. Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. J. Neurosci 2009, 29:14770-14778.
9. Constantinescu C.C., Mukherjee J. Performance evaluation of an Inveon PET preclinical scanner. Phys. Med. Biol 2009, 54:2885-2899.
10. Delatour B., Guégan M., Volk A., Dhenain M. In vivo MRI and histological evaluation of brain atrophy in APP/PS1 transgenic mice. Neurobiol. Aging 2006, 27:835-847.
11. Dodart J.C., Mathis C., Bales K.R., Paul S.M., Ungerer A. Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717F beta-amyloid precursor protein. Neurosci. Lett 1999, 277:49-52.
12. Dubois A., Dauguet J., Herard A.S., Besret L., Duchesnay E., Frouin V., Hantraye P., Bonvento G., Delzescaux T. Automated three-dimensional analysis of histological and autoradiographic rat brain sections: application to an activation study. J. Cereb. Blood Flow Metab 2007, 27:1742-1755.
13. Duyckaerts C., Potier M.C., Delatour B. Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol 2008, 115:5-38.
14. Edison P., Archer H.A., Hinz R., Hammers A., Pavese N., Tai Y.F., Hotton G., Cutler D., Fox N., Kennedy A., Rossor M., Brooks D.J. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology 2007, 68:501-508.
15. El Tannir El Tayara N., Delatour B., Le Cudennec C., Guégan M., Volk A., Dhenain M. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease. Neurobiol. Dis 2006, 22:199-208.
16. Faure A., Verret L., Bozon B., El Tannir El Tayara N., Ly M., Kober F., Dhenain M., Rampon C., Delatour B. Impaired neurogenesis, neuronal loss, and brain functional deficits in the APPxPS1-Ki mouse model of Alzheimer's disease. Neurobiol. Aging 2011, 32:407-418.
17. Gonzalez-Lima F., Berndt J.D., Valla J.E., Games D., Reiman E.M. Reduced corpus callosum, fornix and hippocampus in PDAPP transgenic mouse model of Alzheimer's disease. Neuroreport 2001, 12:2375-2379.
18. Heneka M.T., Ramanathan M., Jacobs A.H., Dumitrescu-Ozimek L., Bilkei-Gorzo A., Debeir T., Sastre M., Galldiks N., Zimmer A., Hoehn M., Heiss W.D., Klockgether T., Staufenbiel M. Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J. Neurosci 2006, 26:1343-1354.
19. Herholz K., Carter S.F., Jones M. Positron emission tomography imaging in dementia. Br. J. Radiol 2007, 80(Spec No 2):S160-S167.
20. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996, 274:99-102.
21. Jellinger K.A., Bancher C. Neuropathology of Alzheimer's disease: a critical update. J. Neural Transm. Suppl 1998, 54:77-95.
22. Kober F., Duhamel G., Cozzone P.J. Experimental comparison of four FAIR arterial spin labeling techniques for quantification of mouse cerebral blood flow at 4.7 T. NMR Biomed 2008, 21:781-792.
23. Kuchibhotla K.V., Lattarulo C.R., Hyman B.T., Bacskai B.J. Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science 2009, 323:1211-1215.
24. Kuntner C., Kesner A.L., Bauer M., Kremslehner R., Wanek T., Mandler M., Karch R., Stanek J., Wolf T., Müller M., Langer O. Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's disease. Mol. Imaging Biol 2009, 11:236-240.
25. LaFerla F.M., Green K.N., Oddo S. Intracellular amyloid-beta in Alzheimer's disease. Nat. Rev. Neurosci 2007, 8:499-509.
26. Langui D., Girardot N., El Hachimi K.H., Allinquant B., Blanchard V., Pradier L., Duyckaerts C. Subcellular Topography of Neuronal Aβ Peptide in APPxPS1 Transgenic Mice. Am. J. Pathol 2004, 165:1465-1477.
27. Luo F., Rustay N.R., Ebert U., Hradil V.P., Cole T.B., Llano D.a., Mudd S.R., Zhang Y., Fox G.B., Day M. Characterization of 7-and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease. Neurobiol. Aging 2010, 10.1016/j.neurobiolaging.2010.08.005.
28. Matsumura A., Mizokawa S., Tanaka M., Wada Y., Nozaki S., Nakamura F., Shiomi S., Ochi H., Watanabe Y. Assessment of microPET performance in analyzing the rat brain under different types of anesthesia: comparison between quantitative data obtained with microPET and ex vivo autoradiography. Neuroimage 2003, 20:2040-2050.
29. Meyer E.P., Ulmann-Schuler A., Staufenbiel M., Krucker T. Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:3587-3592.
30. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur. J. Nucl. Med. Mol. Imaging 2005, 32:486-510.
31. Mosconi L., Tsui W.H., De Santi S., Li J., Rusinek H., Convit A., Li Y., Boppana M., de Leon M.J. Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology 2005, 64:1860-1867.
32. Nestor P.J., Scheltens P., Hodges J.R. Advances in the early detection of Alzheimer's disease. Nat. Med 2004, 10:S34-S41.
33. Nicholson R.M., Kusne Y., Nowak L.A., LaFerla F.M., Reiman E.M., Valla J. Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models. Brain Res 2010, 1347:179-185.
34. Nicolakakis N., Aboulkassim T., Ongali B., Lecrux C., Fernandes P., Rosa-Neto P., Tong X.K., Hamel E. Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist. J. Neurosci 2008, 28:9287-9296.
35. Niwa K., Kazama K., Younkin S.G., Carlson G.A., Iadecola C. Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol. Dis 2002, 9:61-68.
36. Paxinos G., Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates 2001, Academic Press, San Diego. second ed.
37. Phelps M.E. PET Physics, Instrumentation, and Scanners 2006, Springer Science + Business Media, New York.
38. Puzzo D., Privitera L., Leznik E., Fa M., Staniszewski A., Palmeri A., Arancio O. Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J. Neurosci 2008, 28:14537-14545.
39. Reiman E.M., Uecker A., Gonzalez-Lima F., Minear D., Chen K., Callaway N.L., Berndt J.D., Games D. Tracking Alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiography. Neuroreport 2000, 11:987-991.
40. Selkoe D.J. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav. Brain Res 2008, 192:106-113.
41. Shimada H., Ataka S., Tomiyama T., Takechi H., Mori H., Miki T. Clinical Course of Patients with Familial Early-Onset Alzheimer's Disease Potentially Lacking Senile Plaques Bearing the E693δ Mutation in Amyloid Precursor Protein. Dement. Geriatr. Cogn. Disord 2011, 32:45-54.
42. Silverman D.H., Small G.W., Chang C.Y., Lu C.S., Kung De Aburto M.A., Chen W., Czernin J., Rapoport S.I., Pietrini P., Alexander G.E., Schapiro M.B., Jagust W.J., Hoffman J.M., Welsh-Bohmer K.A., Alavi A., Clark C.M., Salmon E., de Leon M.J., Mielke R., Cummings J.L., Kowell A.P., Gambhir S.S., Hoh C.K., Phelps M.E. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA 2001, 286:2120-2127.
43. Sun Y., Schmidt N.O., Schmidt K., Doshi S., Rubin J.B., Mulkern R.V., Carroll R., Ziu M., Erkmen K., Poussaint T.Y., Black P., Albert M., Burstein D., Kieran M.W. Perfusion MRI of U87 brain tumors in a mouse model. Magn. Reson. Med 2004, 51:893-899.
44. Tai Y.C., Ruangma A., Rowland D., Siegel S., Newport D.F., Chow P.L., Laforest R. Performance evaluation of the microPET focus: a third-generation microPET scanner dedicated to animal imaging. J. Nucl. Med 2005, 46:455-463.
45. Toyama H., Ichise M., Liow J.S., Modell K.J., Vines D.C., Esaki T., Cook M., Seidel J., Sokoloff L., Green M.V., Innis R.B. Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography. J. Nucl. Med 2004, 45:1398-1405.
46. Ujiie M., Dickstein D.L., Carlow D.A., Jefferies W.A. Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation 2003, 10:463-470.
47. Valla J., Gonzalez-Lima F., Reiman E.M. FDG autoradiography reveals developmental and pathological effects of mutant amyloid in PDAPP transgenic mice. Int. J. Dev. Neurosci 2008, 26:253-258.
48. Valla J., Schneider L., Reiman E.M. Age- and transgene-related changes in regional cerebral metabolism in PSAPP mice. Brain Res 2006, 1116:194-200.
49. Vlassenko A.G., Vaishnavi S.N., Couture L., Sacco D., Shannon B.J., Mach R.H., Morris J.C., Raichle M.E., Mintun M.A. Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:17763-17767.
50. Williams D.S., Detre J.A., Leigh J.S., Koretsky A.P. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:212-216.
51. Wirths O., Multhaup G., Czech C., Blanchard V., Moussaoui S., Tremp G., Pradier L., Beyreuther K., Bayer T.A. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett 2001, 306:116-120.
52. Yu A.S., Lin H.D., Huang S.C., Phelps M.E., Wu H.M. Quantification of cerebral glucose metabolic rate in mice using 18F-FDG and small-animal PET. J. Nucl. Med 2009, 50:966-973.
53. Zahs K.R., Ashe K.H. "Too much good news"-are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease?. Trends Neurosci 2010, 33:381-389.